FIELD: chemistry; biochemistry.
SUBSTANCE: proposed are human growth hormone conjugates, obtained by removing a hydrogen atom from -NH2 in the Gln side chain which is formed from the human growth hormone or a human growth hormone compound.
EFFECT: design of an efficient method of producing human growth hormone conjugates.
6 cl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INSULIN DERIVATIVE, SOLUBLE PROLONGED PHARMACEUTICAL COMPOSITION, METHOD OF PROLONGATION OF HYPOGLYCAEMIC EFFECT IN TREATMENT OF DIABETIC PATIENTS | 1994 |
|
RU2164520C2 |
| INSULIN DERIVATIVES | 2004 |
|
RU2352581C2 |
| TREATING DIABETES MELLITUS BY INSULIN INJECTIONS AS LITTLE AS ONCE DAY | 2009 |
|
RU2540922C2 |
| INSULIN DERIVATIVES | 2004 |
|
RU2518460C2 |
| PEPTIDE COMPOSITION CONTAINING PROPYLENE GLYCOL OPTIMAL FOR MANUFACTURING AND APPLICATION IN INJECTION DEVICES | 2004 |
|
RU2421238C2 |
| INSULIN PURIFICATION | 2012 |
|
RU2603752C2 |
| STABLE NON-AQUEOUS PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2472492C2 |
| REGENERATION OF CHROMATOGRAPHIC STATIONARY PHASE | 2004 |
|
RU2350945C2 |
| CONJUGATED PROTEINS WITH PROLONGED ACTION IN VIVO | 2009 |
|
RU2526804C2 |
| PRODRUGS CONTAINING EXENDIN CONJUGATE-LINKER | 2011 |
|
RU2593774C2 |
